Pharmaceutical composition for prevention or treatment of flavivirus infection
AssigneesLemonex Inc., Seoul National University R&Db Foundation
InventorsCheol Hee Won, Dal Hee Min
Life of this patent
Estimating the term…
Abstract
A method for treating a flavivirus infection includes administering to a subject in need thereof a composition which includes at least one of gentamicin sulfate, netilmicin, tobramycin, paromomycin, amikacin, capreomycin, trifluoperazine, dihydrostreptomycin, hydroxychloroquine, thioridazine HCl, efavirenz, miltefosine, nystatin, micafungin, bleomycin, resminostat, montelukast, norfloxacin, nedaplatin and cephalothin, which can exhibit excellent growth inhibition or killing effects of various species of flavivirus genus.
Claims15
A method for treating a flavivirus infection, the method comprising administering to a subject in need thereof a composition comprising:
- at least one of paromomycin, capreomycin, thioridazine HCl, miltefosine, resminostat, nedaplatin and cephalothin;
- or at least one of pharmaceutically acceptable salts of the above compounds.
A method for inhibiting growth of flavivirus or killing the same, the method comprising administering to a subject in need thereof a composition comprising:
- at least one of paromomycin, capreomycin, thioridazine HCl, miltefosine, resminostat, nedaplatin and cephalothin;
- and at least one of pharmaceutically acceptable salts of the above compounds.
Dependencies are inferred from the claim text.